Osteoclasts and dendritic cells are derived from monocyte/macrophage precur
sor cells; however, how their lineage commitment is regulated is unknown. T
his study investigated the differentiation pathways of osteoclasts and dend
ritic cells from common precursor cells at the single-cell level. Osteoclas
togenesis induced by macrophage colony-stimulating factor (M-CSF) and recep
tor activator of nuclear factor-kappaB ligand (RANKL) or tumor necrosis fac
tor-alpha (TNF-alpha) is completely inhibited by addition of granulocyte-ma
crophage colony-stimulating factor (GM-CSF) or interleukin-3 at early stage
s of differentiation. GM-CSF-treated cells express both c-Fms and RANK and
also low levels of CD11c and DEC205, which are detected on dendritic cells.
Addition of GM-CSF also reduces expression of both c-Fos and Fra-1, which
is an important event for inhibition of osteoclastogenesis. Overexpression
of c-Fos by retroviral infection or induction in transgenic mice can rescue
a failure in osteoclast differentiation even in the presence of GM-CSF. By
contrast, differentiation into dendritic cells is inhibited by M-CSF, indi
cating that M-CSF and GMCSF reciprocally regulate the differentiation of bo
th lineages. Dendritic cell maturation is also inhibited when c-Fos is expr
essed at an early stage of differentiation. Taken together, these findings
suggest that c-Fos is a key mediator of the lineage commitment between oste
oclasts and dendritic cells. The lineage determination of osteoclast progen
itors seen following GM-CSF treatment functions through the regulation of c
-Fos expression. (Blood. 2001;98:2544-2554) (C) 2001 by The American Societ
y of Hematology.